The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can deliver its most powerful therapy from the very first shock. There’s no need to hold back.
Capabilities and Features:
- Automated defibrillation, with manual override (ECG model only)
- SMART Analysis
- SMART CPR and Quick Shock
- Infant/child defibrillation
- Conscious monitoring with optional FR2+ ECG Assessment Module
- Optional rechargeable battery
- Two display options: text-only, and text with ECG
- Voice and text prompts
- Over 8 hours of data collection
- Programmable voice recording
- Automated self-tests
- "Ready-for-Use" indicator
- Long-life battery: 300 shocks (minimum) or 12 hours monitoring
- Pads can connect to most ALS defibrillator/monitors via pads adapters